XML 57 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1

Percentage of Net Revenue and Total Accounts Receivable (Detail)	3 Months Ended			12 Months Ended
	Jun. 30, 2017		Jun. 30, 2016	Mar. 31, 2017	Mar. 31, 2016
Sales Revenue, Net | Governmental - Medicare/Medi-Cal
Accounts Receivable And Net Revenue [Line Items]
Concentration Risk, Percentage	72.10%		23.60%	18.80%	29.80%
Sales Revenue, Net | L.A Care
Accounts Receivable And Net Revenue [Line Items]
Concentration Risk, Percentage		[1]	14.50%	13.10%	15.70%
Sales Revenue, Net | Allied Physicians [Member]
Accounts Receivable And Net Revenue [Line Items]
Concentration Risk, Percentage		[1]	14.10%	8.50%	0.00%
Sales Revenue, Net | Health Net
Accounts Receivable And Net Revenue [Line Items]
Concentration Risk, Percentage				6.80%	9.90%
Accounts Receivable | Governmental - Medicare/Medi-Cal
Accounts Receivable And Net Revenue [Line Items]
Concentration Risk, Percentage	28.50%			20.50%	39.30%
Accounts Receivable | Allied Physicians [Member]
Accounts Receivable And Net Revenue [Line Items]
Concentration Risk, Percentage	13.80%			12.80%	15.80%
[1] Represents less than 10%

X

- References

No definition available.

+ Details

Name:	ameh_AccountsReceivableAndNetRevenueLineItems
Namespace Prefix:	ameh_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6351-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13531-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84177426&loc=d3e6404-108592

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77997519&loc=d3e13537-108611

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ameh_MedicareAndMedicalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ameh_LCareMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ameh_AlliedPhysiciansMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ameh_HealthnetMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: